Skip to main content
Signal8

SUPRAN BRYAN

SEC insider (Form 3/4/5 filer). CIK 0001511797. EVP, CLO and Secretary at ALNYLAM PHARMACEUTICALS, INC. (ALNY). 3 reported Form 4/5 transactions since Sep 2024; latest on Oct 2, 2026. Located in CAMBRIDGE, MA.

Companies SUPRAN BRYAN has filed insider reports for

  • ALNYLAM PHARMACEUTICALS, INC. (ALNY): Officer, EVP, CLO and Secretary
SUPRAN BRYAN profile photo

SUPRAN BRYAN

CIK: 0001511797

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ALNYLAM PHARMACEUTICALS, INC. logo
ALNY

ALNYLAM PHARMACEUTICALS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • ALNYLAM PHARMACEUTICALS, INC. logo
    ALNY

    ALNYLAM PHARMACEUTICALS, INC.

    Oct 2, 2026
    Sale
    Direct
    1.8K shares at avg. $226.88$399K
  • ALNYLAM PHARMACEUTICALS, INC. logo
    ALNY

    ALNYLAM PHARMACEUTICALS, INC.

    Mar 2, 2026
    Award
    Direct
    1.5K shares-
  • ALNYLAM PHARMACEUTICALS, INC. logo
    ALNY

    ALNYLAM PHARMACEUTICALS, INC.

    Oct 1, 2025
    Award
    Direct
    13K shares-

1-3 of 3